Not investment advice. Educational platform. See Disclaimer.
NYSE: DHR
Danaher Corporation
Healthcare | Medical - Diagnostics & Research
Market prices for DHR are shown to signed-in users (sign in). This public page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.
EPS (TTM)$5.64
Danaher Corporation (NYSE: DHR) is a diagnostics and research company. Figures from SEC EDGAR; updated 2026-10-18 15:12 UTC.
What Danaher Corporation does
Danaher is a science and technology company organized into three segments—Biotechnology, Life Sciences, and Diagnostics—comprising more than operating companies with facilities in approximately countries. The Biotechnology segment provides equipment, consumables, software and services for researching, developing, and manufacturing biological medicines, including therapies for monoclonal antibodies, proteins, vaccines, and cell and gene therapies.
Summarized from Danaher Corporation’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗
Oxford Ledge Signal — extracted from the issuer’s own SEC earnings exhibit and normalized by Oxford Ledge; as reported by the issuer per regulatory convention, not re-audited by us. Source: SEC EDGAR ↗
Every figure in this table is a CHANGE the issuer reported for the period, not a level. Growth rates and levels never share a column or a table -- a change read as a level is a different number entirely.
Oxford Ledge Signal — extracted from the issuer’s own SEC earnings exhibit and normalized by Oxford Ledge; as reported by the issuer per regulatory convention, not re-audited by us. Source: SEC EDGAR ↗
Revenue, margins & earnings
Net income
Taxes & interest
Operating expenses
Cost of revenue
Annual revenue; bands show net, operating, gross margins · Open in Platform →
2026-10-13Exec ChangeDeparture of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officersEstimatedSEC 8-K →
2020-05-06Exec ChangeDeparture of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officersEstimatedSEC 8-K →
2018-11-08Exec ChangeDeparture of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officersEstimatedSEC 8-K →
Danaher is a science and technology company organized into three segments—Biotechnology, Life Sciences, and Diagnostics—comprising more than operating companies with facilities in approximately countries.
When did DHR last file with the SEC?
Danaher Corporation's most recent SEC filing on record is a 8-K filed 2026-06-03. All filings link to their SEC EDGAR originals above.
Where does this data come from?
SEC EDGAR filings, with the company profile (sector, industry, exchange) from public data providers, fetched 2026-10-18 15:12 UTC. This page is also available as JSON at /api/data?ticker=DHR and is emitted with FAQPage structured data for machine reading.
For you
Charts, 10-year financials, peer comparison, screening and portfolio tracking for DHR and 5,000+ tickers.